US Physicalrapy Inc
$ 81.00
0.95%
26 Dec - close price
- Market Cap 1,231,534,000 USD
- Current Price $ 81.00
- High / Low $ 81.39 / 79.10
- Stock P/E 34.18
- Book Value 33.12
- EPS 2.37
- Next Earning Report -
- Dividend Per Share $1.79
- Dividend Yield 2.23 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.08 %
- 52 Week High 92.91
- 52 Week Low 61.67
About
US Physical Therapy, Inc. (USPH) is a leading provider of outpatient physical therapy services, with a strong focus on orthopedic and sports injury rehabilitation, as well as treatment for neurology-related conditions and injured workers. Headquartered in Houston, Texas, the company operates a comprehensive network of clinics across the United States, strategically positioned to capitalize on the growing demand for rehabilitation services driven by demographic trends and an increasing emphasis on health and wellness. USPH's dedication to client-centered, evidence-based care not only optimizes patient recovery but also solidifies its competitive edge in the evolving healthcare market. With a commitment to quality and innovative treatment solutions, USPH is well-equipped to navigate and thrive in the dynamic landscape of healthcare services.
Analyst Target Price
$105.33
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-11 | 2025-08-06 | 2025-05-05 | 2025-02-26 | 2024-11-05 | 2024-08-13 | 2024-05-07 | 2024-02-28 | 2023-11-07 | 2023-08-08 | 2023-05-03 | 2023-02-22 |
| Reported EPS | 0.66 | 0.81 | 0.48 | 0.51 | 0.69 | 0.73 | 0.51 | 0.59 | 0.62 | 0.76 | 0.59 | 0.58 |
| Estimated EPS | 0.67 | 0.7 | 0.4518 | 0.6965 | 0.68 | 0.82 | 0.56 | 0.57 | 0.62 | 0.75 | 0.55 | 0.57 |
| Surprise | -0.01 | 0.11 | 0.0282 | -0.1865 | 0.01 | -0.09 | -0.05 | 0.02 | 0 | 0.01 | 0.04 | 0.01 |
| Surprise Percentage | -1.4925% | 15.7143% | 6.2417% | -26.7767% | 1.4706% | -10.9756% | -8.9286% | 3.5088% | 0% | 1.3333% | 7.2727% | 1.7544% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Dec 2025 | Sep 2025 | Jun 2025 | Apr 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Apr 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2025-12-12 | 2025-09-12 | 2025-06-13 | 2025-04-11 | 2024-12-06 | 2024-09-13 | 2024-06-14 | 2024-04-05 | 2023-12-08 | 2023-09-08 |
| Amount | $0.45 | $0.45 | $0.45 | $0.45 | $0.44 | $0.44 | $0.44 | $0.44 | $0.43 | $0.43 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: USPH
2025-12-29 10:15:33
Harbor Capital Advisors Inc. significantly reduced its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 71% in the third quarter, retaining 6,401 shares valued at approximately $544,000. Despite this reduction in institutional ownership, U.S. Physical Therapy maintains a market capitalization of $1.23 billion, a P/E ratio of 34.03, and pays a quarterly dividend of $0.45. Analyst sentiment for USPH is mixed but leans positive, with an average "Moderate Buy" rating and a consensus price target of $105.33.
2025-12-26 14:20:00
RBC Capital recently upgraded the S&P 500 Health Care sector to "Overweight," positively impacting sentiment for companies like U.S. Physical Therapy (USPH) due to attractive valuations and improving earnings trends. While this shift is favorable, investors in USPH should still focus on the company's core investment narrative, which relies on rising patient volumes, cost efficiencies, and clinic acquisitions to offset persistent reimbursement and labor challenges. Despite the positive sector outlook, individual investors may hold differing fair value estimates for USPH, necessitating a balanced perspective before making investment decisions.
2025-12-25 11:09:44
U.S. Physical Therapy (NYSE:USPH) stock recently surpassed its 200-day moving average of $80.24, trading as high as $81.44 with a volume of 51,239 shares. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $105.33, despite a recent target reduction by JPMorgan. USPH pays a quarterly dividend of $0.45, equating to an annualized yield of approximately 2.2% and a payout ratio of 75.63%.
2025-12-23 15:52:00
This article analyzes U.s. Physical Therapy Inc. (NASDAQ: USPH) for tactical trading, highlighting a mid-channel oscillation pattern and conflicting sentiment across different time horizons. It presents three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for various risk profiles, along with key support and resistance levels. The analysis emphasizes an exceptional risk-reward setup targeting a 12.6% gain against 0.3% risk.
2025-12-23 12:09:58
Shares of U.S. Physical Therapy (USPH) jumped 3.7% after RBC Capital upgraded the S&P 500 Health Care sector to Overweight, citing attractive valuations and improving earnings trends. This broad positive sentiment for the sector contributed to the rise in USPH's shares, though they later cooled down to $80.46, up 3.3% from the previous close. The analyst upgrade outweighed previous concerns about the company's declining year-over-year profitability in a recent quarter, despite revenue growth.
2025-12-23 11:09:33
U.S. Physical Therapy (USPH) saw renewed investor interest after a sector upgrade, with its share price up 12.31% in one month. Despite this, the stock is still below analyst targets, driven by projected annual revenue growth of 8.3% and improved profit margins to 5.7% over three years, suggesting it might be undervalued at $106.83. However, its high P/E ratio compared to the healthcare sector could pose risks if growth doesn't meet expectations.
